Kaeser additionally told the business site that while job creation is “why I've been congratulating the American president for his tax reform, I didn't congratulate him for his first year in office or anything else, but that, I believe, was a job well done."

Siemens decided not to list the Healthineers in the U.S., as reported in January, when it announced that it was planning cost-cutting ahead of its listing on the Frankfurt exchange.


Future strategic plans call for structural changes to save about $293.9 million a year – with the impact of these savings beginning to show in 2020.

The company added no new details of its planned listing in that announcement. Reuters reported at that time that the listing would take place in March, according to unnamed sources.

The announcement of the Frankfurt selection came in November, 2017. At that time, Michael Sen, chairman of the Siemens Healthineers supervisory board and member of Siemens’ managing board, noted that, “Frankfurt is one of the world’s largest trading centers for securities, and its importance will continue to increase due to Brexit. As a highly liquid trading venue, Frankfurt is attractive for investors from around the world. The public listing will give Siemens Healthineers entrepreneurial flexibility and access to the capital market.”

The U.S. had been in contention for the listing in 2017.

In March of that year, however, Kaeser told the Swiss newspaper Finanz and Wirtschaft that he “will have to think twice” about where to list the health care unit, and mentioned Frankfurt and Hong Kong as possibilities, according to Reuters.

Back to HCB News

Business Affairs Homepage